The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathway for gut-brain communication

Department of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.
Neurogastroenterology and Motility (Impact Factor: 3.59). 12/2011; 23(12):1132-9. DOI: 10.1111/j.1365-2982.2011.01796.x
Source: PubMed


The probiotic Bifidobacterium longum NCC3001 normalizes anxiety-like behavior and hippocampal brain derived neurotrophic factor (BDNF) in mice with infectious colitis. Using a model of chemical colitis we test whether the anxiolytic effect of B. longum involves vagal integrity, and changes in neural cell function. Methods  Mice received dextran sodium sulfate (DSS, 3%) in drinking water during three 1-week cycles. Bifidobacterium longum or placebo were gavaged daily during the last cycle. Some mice underwent subdiaphragmatic vagotomy. Behavior was assessed by step-down test, inflammation by myeloperoxidase (MPO) activity and histology. BDNF mRNA was measured in neuroblastoma SH-SY5Y cells after incubation with sera from B. longum- or placebo-treated mice. The effect of B. longum on myenteric neuron excitability was measured using intracellular microelectrodes.
Chronic colitis was associated with anxiety-like behavior, which was absent in previously vagotomized mice. B. longum normalized behavior but had no effect on MPO activity or histological scores. Its anxiolytic effect was absent in mice with established anxiety that were vagotomized before the third DSS cycle. B. longum metabolites did not affect BDNF mRNA expression in SH-SY5Y cells but decreased excitability of enteric neurons.
In this colitis model, anxiety-like behavior is vagally mediated. The anxiolytic effect of B. longum requires vagal integrity but does not involve gut immuno-modulation or production of BDNF by neuronal cells. As B. longum decreases excitability of enteric neurons, it may signal to the central nervous system by activating vagal pathways at the level of the enteric nervous system.

Download full-text


Available from: Amber J. Park, Oct 02, 2014
97 Reads
    • "For example, 3 0 SL and 6 0 SL promoted growth of Bifidobacterium longum in vitro (Yu et al., 2013). B. longum has been shown to improve psychological wellbeing in humans (as assessed by global hospital anxiety and depression scores on the Hopkins symptoms checklist-90) (Messaoudi et al., 2011b) and impact anxiety-like behavior in laboratory animals (Bercik et al., 2011; Savignac et al., 2014). This led us to test whether the administration of 3 0 SL or 6 0 SL could impact stressor-induced anxiety-like behavior. "
    [Show abstract] [Hide abstract]
    ABSTRACT: There are extensive bidirectional interactions between the gut microbiota and the central nervous system (CNS), and studies demonstrate that stressor exposure significantly alters gut microbiota community structure. We tested whether oligosaccharides naturally found in high levels in human milk, which have been reported to impact brain development and enhance the growth of beneficial commensal microbes, would prevent stressor-induced alterations in gut microbial community composition and attenuate stressor-induced anxiety-like behavior. Mice were fed standard laboratory diet, or laboratory diet containing the human milk oligosaccharides 3'Sialyllactose (3'SL) or 6'Sialyllactose (6'SL) for 2weeks prior to being exposed to either a social disruption stressor or a non-stressed control condition. Stressor exposure significantly changed the structure of the colonic mucosa-associated microbiota in control mice, as indicated by changes in beta diversity. The stressor resulted in anxiety-like behavior in both the light/dark preference and open field tests in control mice. This effect was associated with a reduction in immature neurons in the dentate gyrus as indicated by doublecortin (DCX) immunostaining. These effects were not evident in mice fed milk oligosaccharides; stressor exposure did not significantly change microbial community structure in mice fed 3'SL or 6'SL. In addition, 3'SL and 6'SL helped maintain normal behavior on tests of anxiety-like behavior and normal numbers of DCX+ immature neurons. These studies indicate that milk oligosaccharides support normal microbial communities and behavioral responses during stressor exposure, potentially through effects on the gut microbiota-brain axis. Copyright © 2015. Published by Elsevier Inc.
    Brain Behavior and Immunity 07/2015; DOI:10.1016/j.bbi.2015.06.025 · 5.89 Impact Factor
  • Source
    • "t pathways and mediators of this effect are yet to be elucidated . Commensal bacteria might modulate brain biochemistry and behaviour through the production of specific metabolites ( Lyte , 2011 ; Barrett et al . 2012a , b ; Hsiao et al . 2013 ) . It has been shown previously that commensal bacteria can modulate behaviour through the vagus nerve ( Bercik et al . 2011b ; Bravo et al . 2011 ) , affecting neurotransmitter metabolism ( Asano et al . 2012 ) , or through alternative pathways , yet to be defined ( Bercik et al . 2010 , 2011a ) . It is plausible to postulate that in the future the manipulation of gut microbiota , through probiotics or symbiotics , might be a valuable adjuvant to traditional "
    [Show abstract] [Hide abstract]
    ABSTRACT: The gut-brain axis is the bi-directional communication between the gut and the brain which occurs through multiple pathways that include hormonal, neural and immune mediators. The signals along this axis can originate in the gut, the brain, or both, with the objective of maintaining normal gut function and appropriate behavior. In recent years, the study of gut microbiota has become one of the most important areas in biomedical research. Attention has focused on the role of gut microbiota in determining normal gut physiology and immunity, and more recently on its role as modulator of host behavior ("microbiota-gut-brain axis"). We therefore review the literature on the role of gut microbiota in gut homeostasis and link it with mechanisms that could influence behavior. We discuss the association of dysbiosis with disease with particular focus on functional bowel disorders and its relation to psychological stress. This is of particular interest as exposure to stressors has long been known to increase susceptibility to and severity of gastrointestinal diseases.
    The Journal of Physiology 04/2014; 592(14). DOI:10.1113/jphysiol.2014.273995 · 5.04 Impact Factor
  • Source
    • "The potential for gut microorganisms to influence brain responses in humans has been illustrated by the finding of reduced activation of brain centres involved in emotional responses with the administration of fermented milk products with probiotics (Tillish et al. 2013). In animal models, products of microbiota may also affect the excitability of enteric neurons (Bercik et al. 2011) and vagal afferents (Bravo et al. 2011). Immune activation and minimal inflammation ( ¨ Ohman & Simrén, 2010), manifesting as increased T lymphocytes and mast cells in rectal mucosa in patients with IBS, were associated with increased intestinal permeability (Spiller et al. 2000) and functional alterations of several components of the host mucosal immune response to microbial pathogens (Aerssens et al. 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The gastrointestinal tract is a vast neuroendocrine organ with extensive extrinsic and intrinsic neural circuits that interact to control its function. Circulating and paracrine hormones (amine and peptide) provide further control of secretory, absorptive, barrier, motor and sensory mechanisms that are essential to the digestion and assimilation of nutrients, and the transport and excretion of waste products. Specialized elements of the mucosa (including enteroendocrine cells, enterocytes and immune cells) and the microbiome interact with other intraluminal contents derived from the diet, and with endogenous chemicals that alter the gut's functions. The totality of these control mechanisms is often summarized as the brain-gut axis. In irritable bowel syndrome, which is the most common gastrointestinal disorder experienced by patients, there may be disturbances at one or more of these diverse control mechanisms. Patients present with abdominal pain in association with alteration of bowel function. This review documents advances in understanding the pathophysiological mechanisms in the brain-gut axis in patients with IBS. It is anticipated that identification of the one or more disordered functions in clinical practice will usher in a renaissance in IBS, leading to effective therapy tailored to the needs of the individual patient.
    The Journal of Physiology 03/2014; 592(14). DOI:10.1113/jphysiol.2014.270892 · 5.04 Impact Factor
Show more